223 related articles for article (PubMed ID: 2991605)
21. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
Lovmand J; Sorensen AB; Schmidt J; Ostergaard M; Luz A; Pedersen FS
J Virol; 1998 Jul; 72(7):5745-56. PubMed ID: 9621033
[TBL] [Abstract][Full Text] [Related]
22. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK; An DS; Chen IS
J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
[TBL] [Abstract][Full Text] [Related]
23. Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity.
Hollon T; Yoshimura FK
J Virol; 1989 Aug; 63(8):3353-61. PubMed ID: 2545910
[TBL] [Abstract][Full Text] [Related]
24. Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion.
Corcoran LM; Adams JM; Dunn AR; Cory S
Cell; 1984 May; 37(1):113-22. PubMed ID: 6327047
[TBL] [Abstract][Full Text] [Related]
25. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
[TBL] [Abstract][Full Text] [Related]
26. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
27. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus.
Portis JL; Czub S; Garon CF; McAtee FJ
J Virol; 1990 Apr; 64(4):1648-56. PubMed ID: 2181155
[TBL] [Abstract][Full Text] [Related]
28. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
Tupper JC; Chen H; Hays EF; Bristol GC; Yoshimura FK
J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
[TBL] [Abstract][Full Text] [Related]
30. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.
Tumas KM; Poszgay JM; Avidan N; Ksiazek SJ; Overmoyer B; Blank KJ; Prystowsky MB
Virology; 1993 Feb; 192(2):587-95. PubMed ID: 7678475
[TBL] [Abstract][Full Text] [Related]
31. Localization of the leukemogenic determinants of SL3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin.
Lenz J; Haseltine WA
J Virol; 1983 Aug; 47(2):317-28. PubMed ID: 6312068
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.
Cupelli LA; Lenz J
J Virol; 1991 Dec; 65(12):6961-8. PubMed ID: 1658385
[TBL] [Abstract][Full Text] [Related]
33. Nucleotide sequence and mode of transmission of the wild mouse ecotropic virus, HoMuLV.
Voytek P; Kozak CA
Virology; 1989 Nov; 173(1):58-67. PubMed ID: 2554579
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide sequence of AKV murine leukemia virus.
Herr W
J Virol; 1984 Feb; 49(2):471-8. PubMed ID: 6319746
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
Morrison HL; Dai HY; Pedersen FS; Lenz J
J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
[TBL] [Abstract][Full Text] [Related]
36. Chimeras between SRS and Moloney murine leukemia viruses reveal novel determinants in disease specificity and MCF recombinant formation.
Jahid S; Bundy LM; Granger SW; Fan H
Virology; 2006 Jul; 351(1):7-17. PubMed ID: 16616947
[TBL] [Abstract][Full Text] [Related]
37. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
[TBL] [Abstract][Full Text] [Related]
38. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
Masuda M; Remington MP; Hoffman PM; Ruscetti SK
J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
[TBL] [Abstract][Full Text] [Related]
40. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
Vogt M; Haggblom C; Swift S; Haas M
J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
